City Therapeutics

CTY
18.1004.64% ( -0.880 )
Closed: Nov 13, 16:00:00 (EDT)

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: City Therapeutics(CTY) the Revenue is 3.179 M (+13.98%);the EBIT is -25.57 M (-92.27%);the EPS is -4.34 (-57.2%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B13.98%
----
----
EBIT
-0.03B92.27%
----
----
EPS
-4.337257.20%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 24, 2026
Estimate Revenue7.5 M
Estimate EBIT-23.83 M
Estimate EPS-3.135

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly